Good Distribution Practices News

02.09.21

New MHRA Inspectorate Blog GDP Post: Protecting the UK Medicines Supply Chain

One of the objectives of Good Distribution Practice (GDP) and an important aspect for distributors of medicinal products is preventing falsified medicines entering the legal supply chain. In this context, a new post, entitled "Too good to be true? How to play your part in protecting the UK medicines supply chain" has been published on the MHRA Inspectorate blog.

02.09.21

European GDP Association publishes new Q&A Document

In October 2020, the ECA Academy offered the Live Online Training "The GDP Compliance Manager". During the Q&A sessions, many interesting questions were posed to the speakers' team. The European GDP Association has answered these questions and combined them in a Q&A document.

27.07.21

CJEU Judgement on OTC Medicines

In a recently published ruling, the Court of Justice of the European Union (CJEU) decided that a medicinal product not subject to medical prescription in one Member State may not automatically be placed on the market in another Member State. Rather, the medicinal product may only be placed on the market in a Member State if the competent authority of that Member State or the EU Commission has granted its marketing authorisation.

27.07.21

Acting as a Responsible Person (import) (RPi): MHRA concretises Eligibility Criteria

Last year, the Medicines and Healthcare products Regulatory Agency (MHRA) published a guidance called "Acting as a Responsible Person (import) ". The guidance describes the role of the Responsible Person (import) (RPi) and how to become a RPi. This guidance was now updated, listing extensive qualification requirements for RPi's.

27.07.21

European GDP Association nominates Alfred Hunt as new Advisory Board Member and Deputy Chair

The European GDP Association, representing about 3.500 professionals from across the globe, has extended its Board. Alfred Hunt was invited to join the Advisory Board and accepted to take over the role as a Deputy Chair.

01.07.21

EMA publishes Q&A Document about Parallel Distribution

Parallel distribution is defined as the distribution of a centrally authorised medicinal product from one Member State to another by a pharmaceutical company independent of the marketing-authorisation holder. In this context, the European Medicines Agency (EMA) has recently published a new comprehensive Q&A document containing answers to the most common questions.

01.07.21

Questions & Answers on Good Distribution Practices (GDP) - Part 5

In October 2020, the ECA Academy offered the Live Online Training "The GDP Compliance Manager". During the Q&A sessions, many interesting questions were posed to the speakers' team. The ECA would like to share a selection of these Q&As sorted by topic. Part 5 deals with questions related to deviations.

16.06.21

New Version of the Q&As on Safety Features for Track & Trace

The European Commission has published Version 18b of the "Questions & Answers" on safety features. In particular the update took into account the new ISO standard for Packaging Tamper verification features.

01.06.21

Recall of Product Samples from U.S. Market Due to Improper Storage Temperature Conditions

A global healthcare company is voluntarily recalling 1,468 product samples from the U.S. market because they were stored at temperatures below storage requirements. The products affected are used to lower blood glucose levels in people with diabetes. The recall is being conducted with the knowledge of the U.S. Food and Drug Administration (FDA).

01.06.21

Questions & Answers on Good Distribution Practices (GDP) - Part 4

In October 2020, the ECA Academy offered the Live Online Training "The GDP Compliance Manager". During the Q&A sessions, many interesting questions were posed to the speakers' team. The ECA would like to share a selection of these Q&As sorted by topic. Part 4 deals with questions related to documentation.

01.06.21

FIFO, FEFO, LIFO: What is the meaning?

FIFO, FEFO and LIFO are the three main strategies for warehouse management. But what do the three abbreviations actually stand for and what exactly do they mean?

27.04.21

Questions & Answers on Good Distribution Practices (GDP) - Part 3

In October 2020, the ECA Academy offered the Live Online Training "The GDP Compliance Manager". During the Q&A sessions, many interesting questions were posed to the speakers' team. The ECA would like to share a selection of these Q&As sorted by topic. Part 3 deals with questions related to the Quality Management System (QMS).

27.04.21

GDP-Non-Compliance-Report for German Wholesale Distributor

The Competent Authority of Germany (Bezirksregierung Düsseldorf) has entered a new GPD Non-Compliance Report dated into the EudraGMDP database due to serious GDP violations at a German wholesaler. The case involves trading of falsified medicinal products and storage of expired medicinal products in regular stock. Furthermore, there are doubts on the reliability of the Reponsible Person and the CEO due to an ongoing criminal procedure.

27.04.21

GDP Non-Compliance Report for Romanian Wholesale Distributor

The competent authority of Romania (National Agency for Medicines and Medical Devices of Romania) has entered a new GPD Non-Compliance Report dated 15 April 2021 into the EudraGMDP database.

21.04.21

Track & Trace: Amendment of the Delegated Regulation on Safety Features

On 17 March 2021, the Delegated Regulation (EU) 2021/457 was published in the Official Journal of the European Union. It amends the Delegated Regulation 2016/161 regarding an exemption from the obligation for wholesalers to decommission the unique identifier (UI) of medicinal products exported to the UK.

Page 10 of 24

Recommended Event

Berlin, Germany

14/15 May 2024

GMP SEARCH ENGINE

Good Distribution Practices News

New MHRA Inspectorate Blog GDP Post: Protecting the UK Medicines Supply Chain

European GDP Association publishes new Q&A Document

CJEU Judgement on OTC Medicines

Acting as a Responsible Person (import) (RPi): MHRA concretises Eligibility Criteria

European GDP Association nominates Alfred Hunt as new Advisory Board Member and Deputy Chair

EMA publishes Q&A Document about Parallel Distribution

Questions & Answers on Good Distribution Practices (GDP) - Part 5

New Version of the Q&As on Safety Features for Track & Trace

Recall of Product Samples from U.S. Market Due to Improper Storage Temperature Conditions

Questions & Answers on Good Distribution Practices (GDP) - Part 4

FIFO, FEFO, LIFO: What is the meaning?

Questions & Answers on Good Distribution Practices (GDP) - Part 3

GDP-Non-Compliance-Report for German Wholesale Distributor

GDP Non-Compliance Report for Romanian Wholesale Distributor

Track & Trace: Amendment of the Delegated Regulation on Safety Features

Recommended Event

Blood, Blood Products and Plasma Quality, Safety, SoHO and recent Developments

Good Distribution Practices News

New MHRA Inspectorate Blog GDP Post: Protecting the UK Medicines Supply Chain

European GDP Association publishes new Q&A Document

CJEU Judgement on OTC Medicines

Acting as a Responsible Person (import) (RPi): MHRA concretises Eligibility Criteria

European GDP Association nominates Alfred Hunt as new Advisory Board Member and Deputy Chair

EMA publishes Q&A Document about Parallel Distribution

Questions & Answers on Good Distribution Practices (GDP) - Part 5

New Version of the Q&As on Safety Features for Track & Trace

Recall of Product Samples from U.S. Market Due to Improper Storage Temperature Conditions

Questions & Answers on Good Distribution Practices (GDP) - Part 4

FIFO, FEFO, LIFO: What is the meaning?

Questions & Answers on Good Distribution Practices (GDP) - Part 3

GDP-Non-Compliance-Report for German Wholesale Distributor

GDP Non-Compliance Report for Romanian Wholesale Distributor

Track & Trace: Amendment of the Delegated Regulation on Safety Features

Recommended Event

Blood, Blood Products and Plasma Quality, Safety, SoHO and recent Developments

GMP Newsletter

GMP Conferences by Topics